Your browser doesn't support javascript.
loading
Chemical modification of hyaluronic acid improves its supportive action on embryo implantation.
Ganji, Roya; Mashayekhan, Shohreh; Abandansari, Hamid Sadeghi; Aflatoonian, Reza; Ghanian, Mohammad-Hossein; Eftekhari-Yazdi, Poopak.
Afiliação
  • Ganji R; Department of Developmental Biology, University of Science and Culture, Tehran, Iran; Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
  • Mashayekhan S; Department of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran.
  • Abandansari HS; Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Aflatoonian R; Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute, ACECR, Tehran, Iran.
  • Ghanian MH; Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Electronic address: ghanian@royaninstitute.org.
  • Eftekhari-Yazdi P; Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Electronic address: eftekhari@royaninstitute.org.
Int J Biol Macromol ; 222(Pt A): 198-206, 2022 Dec 01.
Article em En | MEDLINE | ID: mdl-36130644
ABSTRACT
Hyaluronic acid (HA) is a supplement of the embryo transfer medium that improves embryo implantation. We have suggested that the supportive action of HA can be promoted by introducing additional artificial binding sites on the HA structure. HA was modified at carboxyl sites separately with thiol (SH) and N-hydroxysuccinimide (NHS), as mucoadhesive and amine-reactive groups, respectively. The mouse blastocysts were incubated with HA derivatives for 15 min. The HA coatings maintained their potential for enzymatic degradation and showed no detrimental effect on embryonic viability and developmental potential. After in vivo transfer, a significantly higher implantation rate was attained by HA-NHS treatment (80 %) compared with the HA-SH (53 %) and the commercial transfer medium, EmbryoGlue® (56 %). The HA-NHS was produced by a slight modification on the native structure of HA using a simple, fast, non-expensive and scalable chemistry which all promise applicability of this new HA derivative in assisted reproductive technologies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Implantação do Embrião / Ácido Hialurônico Limite: Animals Idioma: En Revista: Int J Biol Macromol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Implantação do Embrião / Ácido Hialurônico Limite: Animals Idioma: En Revista: Int J Biol Macromol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã
...